论文部分内容阅读
目的研究美托洛尔治疗慢性心力衰竭(CHF)的疗效。方法将我院收治的60例CHF患者随机分为治疗组和对照组,每组各30例,对照组给予常规抗心衰治疗,治疗组在此基础上加用美托洛尔,疗程均6月,于治疗前后测定两组左室射血分数(LVEF)、心率、血压、不良反应等。结果治疗组左室射血分数较前改善,心率、血压下降、总有效率明显高于对照组,差异有统计学意义(P<0.05)。结论美托洛尔能明显改善患者临床症状和心功能。
Objective To study the efficacy of metoprolol in the treatment of chronic heart failure (CHF). Methods Sixty CHF patients admitted to our hospital were randomly divided into treatment group and control group, with 30 cases in each group. The control group was given routine anti-heart failure treatment. On the basis of this treatment, metoprolol was added to the treatment group, all of which were treated 6 Month, before and after treatment, two groups were measured left ventricular ejection fraction (LVEF), heart rate, blood pressure, adverse reactions. Results The left ventricular ejection fraction improved, the heart rate and blood pressure decreased, and the total effective rate in the treatment group was significantly higher than that in the control group (P <0.05). Conclusion Metoprolol can significantly improve clinical symptoms and cardiac function in patients.